Danek Stella, Achelrod Dmitrij, Wichmann Ole, Schwendicke Falk
Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Oral Diagnostics, Digital Health and Health Services Research, Assmannshauser Straβe 4-6, 14197 Berlin, Germany.
Independent Researcher.
Vaccines (Basel). 2023 Sep 30;11(10):1552. doi: 10.3390/vaccines11101552.
During the COVID-19 vaccination campaign, Germany, like other high-income countries, introduced mass vaccination centers for administering vaccinations. This qualitative study aimed to examine the role that these novel, temporary government healthcare structures played in a mass immunization roll-out and how they can be optimally deployed. In addition, learnings for general emergency preparedness were explored. A total of 27 high-level policymakers responsible for planning and implementing the COVID vaccination campaign at the national and state level in Germany were interviewed in May and June 2022. The semi-structured interviews were analyzed using thematic analysis. Interviewees indicated that mass vaccination structures played an essential role with respect to controllability, throughput, accessibility and openness in line with the key success criteria vaccination coverage, speed and accessibility. In contrast to the regular vaccination structures (private medical practices and occupational health services), public administration has direct authority over mass vaccination centers, allowing for reliable vaccine access prioritization and documentation. The deployment of vaccination centers should be guided by vaccine availability and demand, and vaccine requirements related to logistics, as well as local capacities, i.e., public-health-service strength and the physician density, to ensure effective, timely and equitable access. Improvements to the capacity use, scalability and flexibility of governmental vaccination structures are warranted for future pandemics.
在新冠疫苗接种运动期间,德国与其他高收入国家一样,设立了大规模疫苗接种中心来进行疫苗接种。这项定性研究旨在考察这些新型的临时政府医疗结构在大规模免疫接种推广中所起的作用,以及如何对其进行优化部署。此外,还探讨了对一般应急准备工作的经验教训。2022年5月和6月,对德国负责国家和州层面新冠疫苗接种运动规划与实施的27名高级政策制定者进行了访谈。采用主题分析法对这些半结构化访谈进行了分析。受访者表示,大规模疫苗接种结构在可控性、接种量、可及性和开放性方面发挥了重要作用,符合疫苗接种覆盖率、速度和可及性等关键成功标准。与常规疫苗接种结构(私人医疗诊所和职业健康服务机构)不同,公共行政部门对大规模疫苗接种中心拥有直接管辖权,这使得能够对疫苗获取进行可靠的优先级排序和记录。疫苗接种中心的部署应以疫苗供应和需求、与物流相关的疫苗要求以及当地能力,即公共卫生服务实力和医生密度为指导,以确保有效、及时和公平的获取。为应对未来的大流行,有必要提高政府疫苗接种结构的产能利用率、可扩展性和灵活性。